Grzegorz S Nowakowski, MD

  • 4290 Citations
  • 41 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Grzegorz S Nowakowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Survival Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 4290 Citations
  • 41 Scopus h-Index
  • 126 Article
  • 7 Review article
  • 3 Letter
  • 1 Comment/debate

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease
20 Citations (Scopus)

AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., Pinto, A., Re, F., Fogliatto, L. M., Scheinberg, P., Flinn, I. W., Moreira, C., Cabeçadas, J., Liu, D., Kalambakas, S., Fustier, P. & 2 others, Wu, C. & Gribben, J. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1188-1199 12 p.

Research output: Contribution to journalArticle

Open Access
Lymphoma
Placebos
Neutropenia
Disease-Free Survival
lenalidomide
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival

End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma

Kostakoglu, L. & Nowakowski, G. S., Jul 1 2019, In : PET Clinics. 14, 3, p. 307-315 9 p.

Research output: Contribution to journalReview article

Lymphoma, Large B-Cell, Diffuse
tomography
Tomography
Disease-Free Survival
progressions
1 Citation (Scopus)

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Wang, Y., Link, B. K., Witzig, T. E., Maurer, M. J., Allmer, C., King, R. L., Feldman, A. L., Habermann, T. M., Ansell, S. M., Slager, S. L., Cerhan, J. R. & Nowakowski, G. S., Oct 17 2019, In : Blood. 134, 16, p. 1289-1297 9 p.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
Lymphoma
Hazards
Cells
Germinal Center